On September 7, 2017, the Institut national d’excellence en santé et en services sociaux (INESSS) released the list of medications for which a registration application was submitted for the February 2018 list update as well as the medications pending a Health Canada Notice of Compliance to be reviewed.

Health professionals, citizens, patients and their associations and groups may submit comments on any of the drug products under review by October 10, 2017. To do so, INESSS invites you to complete one of the two new questionnaires on the INESSS website. One questionnaire is for the patients’ associations and groups and the other one is for the patients themselves and their loved ones. The objective of these questionnaires is to better understand the impact of the disease and treatments on their lives and that of their loved ones and to take this into consideration while reviewing and evaluating the drug product.

Please refer to INESSS’ work plan for all medications under review.

For further information, please refer to the INESSS website.